Vistagen Therapeutics Inc (NASDAQ:VTGN)
| 4.88 Delayed Data As of Dec 07 |  +0.45 / +10.16%Today’s Change | 1.62 Today|||52-Week Range 24.71 | +57.93% Year-to-Date |
Latest VTGN News | Press Releases
No recent news for Vistagen Therapeutics Inc.
Today’s Trading
| Previous close | 4.43 |
| Today’s open | 4.85 |
| Day’s range | 4.56 - 5.16 |
| Volume | 42,611 |
| Average volume (3 months) | 1,632,007 |
| Market cap | $98.6M |
Data as of 3:59pm ET, 12/07/2023
Growth & Valuation
| Earnings growth (last year) | -15.36% |
| Earnings growth (this year) | -5.76% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -120.50% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PSNLPersonalis Inc | 0.00 | 0.00% |
| ---- | ||
| STOKStoke Therapeutics I... | +0.40 | +9.50% |
| ---- |
Data as of 3:59pm ET, 12/07/2023
Financials
| Next reporting date | February 14, 2024 |
| EPS forecast (this quarter) | -$1.22 |
| Annual revenue (last year) | -$227.3K |
| Annual profit (last year) | -$59.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
